Article

Clinical Significance of MTAP Deletion in Pancreatic Ductal Adenocarcinoma: A Real-World US Patient Cohort Study

2026-08-03

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> <italic>MTAP</italic> deletion is a common mutation in pancreatic ductal adenocarcinoma (PDAC). With the emergence of MTA-cooperative PRMT5 inhibitors, real-world evidence from representative patient populations is needed to understand the clinical significance of <italic>MTAP</italic> deletion and inform future treatment decisions. This retrospective cohor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 18a8e57f-6454-50b5-873c-bb4ddef6829f
DOI: 10.21203/rs.3.rs-10359117/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance of MTAP Deletion in Pancreatic Ductal Adenocarcinoma: A Real-World US Patient Cohort StudyDOI 10.21203/rs.3.rs-10359117/v1Read

Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma.Semantic proximity Read

Clinical study of genomic drivers in pancreatic ductal adenocarcinomaSemantic proximity Read

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsSemantic proximity Read

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.Semantic proximity Read

Whole exome sequencing and RNA sequencing analyses of PDAC samplesSemantic proximity Read

Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.Semantic proximity Read

Clinical utility of molecular subtyping of pancreatic cancerSemantic proximity Read

Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern.Semantic proximity Read

Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.Semantic proximity Read

Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.Semantic proximity Read

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as BiomarkersSemantic proximity Read

Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development.Semantic proximity Read